Q-omics provides the consensus-scored LINC00604 profile across patient tissues and cancer cell-line models. LINC00604 expression is associated with patient survival in 12 of 34 cancer types, with the highest sampling consensus in TGCT. Additionally, LINC00604 RNA expression shows 5,964 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight TGCT, and STAD as cancer lineages where LINC00604 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.